Quarterly Results

PLETHICO PHARMACEUTICALS LTD.

NSE : NABSE : 532739ISIN CODE : INE491H01018Industry : Pharmaceuticals & DrugsHouse : Private
BSE7.940 (0 %)
PREV CLOSE ( ) 7.94
OPEN PRICE ( ) 8.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 10351
TODAY'S LOW / HIGH ( )7.94 8.30
52 WK LOW / HIGH ( ) 7.948.3
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Mar 2015
Dec 2014
Sep 2014
Jun 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1128.43
1114.49
2629.64
2778.77
Total Expenditure
1201.23
931.12
2113.16
2272.31
PBIDT (Excl OI)
-72.8
183.37
516.48
506.46
Other Income
-1.53
1.26
4.3
-4.04
Operating Profit
-74.33
184.63
520.78
502.42
Interest
215.97
117.04
519.94
362.54
Exceptional Items
-3195.58
NA
NA
NA
PBDT
-3485.88
67.59
0.84
139.88
Depreciation
164.26
108.25
154.16
152.35
Profit Before Tax
-3650.14
-40.66
-153.32
-12.47
Tax
-993.41
NA
-90.25
4.29
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-2656.73
-40.66
-63.07
-16.76
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-2656.73
-40.66
-63.07
-16.76
Minority Interest
NA
NA
NA
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-2656.73
-40.66
-63.07
-16.76
Equity Capital
340.67
340.67
340.67
340.67
Face Value (IN RS)
10
10
10
10
Reserves
NA
NA
NA
NA
Calculated EPS
-77.98
-1.19
-1.85
-0.49
Calculated EPS (Annualised)
-311.94
-4.77
-7.40
-1.96
No of Public Share Holdings
9645975
9645975
9650237
9335737
% of Public Share Holdings
28.31
28.31
28.33
27.4
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-6.45
16.45
19.64
18.22
PBIDTM%
-6.58
16.56
19.80
18.08
PBDTM%
-308.91
6.06
0.03
5.03
PBTM%
-323.47
-3.64
-5.83
-0.44
PATM%
-235.43
-3.64
-2.39
-0.60
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.